Inverse, protean, and ligand‐selective agonism: matters of receptor conformation

T Kenakin - The FASEB journal, 2001 - Wiley Online Library
Concepts regarding the mechanisms by which drugs activate receptors to produce
physiological response have progressed beyond considering the re¬ ceptor as a simple on …

Efficacy as a vector: the relative prevalence and paucity of inverse agonism

T Kenakin - Molecular pharmacology, 2004 - ASPET
This article describes the expected phenotypic behavior of all types of ligands in
constitutively active receptor systems and, in particular, the molecular mechanisms of …

Complete sequence of a novel protein containing a femtomolar‐activity‐dependent neuroprotective peptide

M Bassan, R Zamostiano, A Davidson… - Journal of …, 1999 - Wiley Online Library
The vulnerability of neurons and the irreversibility of loss make discoveries of
neuroprotective compounds fundamentally important. Here, the complete coding sequence …

The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

EM Lutz, WJ Sheward, KM West, JA Morrow… - FEBS …, 1993 - Wiley Online Library
We have cloned and sequenced a cDNA (RPR4) encoding a new member of the
secretin/calcitonin/parathyroid hormone (PTH) receptor family. RPR4 was identified by PCR …

Cloning and characterization of the human activity-dependent neuroprotective protein

R Zamostiano, A Pinhasov, E Gelber… - Journal of Biological …, 2001 - ASBMB
We have recently cloned the mouse activity-dependent neuroprotective protein (ADNP).
Here, we disclose the cloning of human ADNP (hADNP) from a fetal brain cDNA library …

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

P Gressens, JM Hill, I Gozes, M Fridkin, DE Brenneman - Nature, 1993 - nature.com
FACTORS controlling central nervous system (CNS) growth immediately after neurulation
are mostly unknown. Vasoactive intestinal peptide (VIP) receptors are widely distributed in …

A femtomolar-acting neuroprotective peptide.

DE Brenneman, I Gozes - The Journal of clinical …, 1996 - Am Soc Clin Investig
A novel 14-amino acid peptide, with stress-protein-like sequences, exhibiting
neuroprotection at unprecedented concentrations, is revealed. This peptide prevented …

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

I Gozes, A Bardea, A Reshef… - Proceedings of the …, 1996 - National Acad Sciences
Neurodegenerative diseases, in which neuronal cell disintegrate, bring about deteriorations
in cognitive functions as is evidenced in millions of Alzheimer patients. A major …

Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze

I Gozes, E Giladi, A Pinhasov, A Bardea… - … of Pharmacology and …, 2000 - ASPET
Activity-dependent neurotrophic factor (ADNF) is a glia-derived protein that is
neuroprotective at femtomolar concentrations. A nine-amino acid peptide derived from …

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

P Gourlet, P De Neef, J Cnudde, M Waelbroeck… - Peptides, 1997 - Elsevier
Gourlet, P., P. De Neef, J. Cnudde, M. Waelbroeck and P. Robberecht. In vitro properties of a
high affinity selective antagonist of the VIP1 receptor. Peptides 18 (10) 1555–1560, 1997 …